Changing the paradigm on LDL-c-lowering in high CV risk patients
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Redefining intensive LDL-c management in high CV risk patients - The case for combination therapyExpanding therapeutic options for LDL-c lowering
Christie Ballantyne, MD
- Redefining intensive LDL-c management in high CV risk patients - The case for combination therapyCombination therapy with PCSK9 mAbs in post-MI patients
Derek Connolly, MD, PhD
